BIO-TECHNE Corp (TECH) fundamentals from SEC filings — revenue $1.2B, net margin 15.0%, diluted EPS $1.16 in FY2026. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B |
| Net income | $272.1M | $285.3M | $168.1M | $73.4M | $181.9M |
| Net margin | 24.6% | 25.1% | 14.5% | 6.0% | 15.0% |
| Diluted EPS | $1.66 | $1.76 | $1.05 | $0.46 | $1.16 |
| Free cash flow | $280.4M | $216.1M | $236.1M | $256.6M | $263.2M |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home